اشترك بالحزمة الذهبية واحصل على وصول غير محدود شمرا أكاديميا
تسجيل مستخدم جديدInvestigating the Detection of Adverse Drug Events in a UK General Practice Electronic Health-Care Database
55
0
0.0
(
0
)
اسأل ChatGPT حول البحث
ﻻ يوجد ملخص باللغة العربية
Data-mining techniques have frequently been developed for Spontaneous reporting databases. These techniques aim to find adverse drug events accurately and efficiently. Spontaneous reporting databases are prone to missing information, under reporting and incorrect entries. This often results in a detection lag or prevents the detection of some adverse drug events. These limitations do not occur in electronic health-care databases. In this paper, existing methods developed for spontaneous reporting databases are implemented on both a spontaneous reporting database and a general practice electronic health-care database and compared. The results suggests that the application of existing methods to the general practice database may help find signals that have gone undetected when using the spontaneous reporting system database. In addition the general practice database provides far more supplementary information, that if incorporated in analysis could provide a wealth of information for identifying adverse events more accurately.
قيم البحث
اقرأ أيضاً
The wealth of computerised medical information becoming readily available presents the opportunity to examine patterns of illnesses, therapies and responses. These patterns may be able to predict illnesses that a patient is likely to develop, allowin
g the implementation of preventative actions. In this paper sequential rule mining is applied to a General Practice database to find rules involving a patients age, gender and medical history. By incorporating these rules into current health-care a patient can be highlighted as susceptible to a future illness based on past or current illnesses, gender and year of birth. This knowledge has the ability to greatly improve health-care and reduce health-care costs.
Computational auditory scene analysis is gaining interest in the last years. Trailing behind the more mature field of speech recognition, it is particularly general sound event detection that is attracting increasing attention. Crucial for training a
nd testing reasonable models is having available enough suitable data -- until recently, general sound event databases were hardly found. We release and present a database with 714 wav files containing isolated high quality sound events of 14 different types, plus 303 `general wav files of anything else but these 14 types. All sound events are strongly labeled with perceptual on- and offset times, paying attention to omitting in-between silences. The amount of isolated sound events, the quality of annotations, and the particular general sound class distinguish NIGENS from other databases.
We introduce Bi-GNN for modeling biological link prediction tasks such as drug-drug interaction (DDI) and protein-protein interaction (PPI). Taking drug-drug interaction as an example, existing methods using machine learning either only utilize the l
ink structure between drugs without using the graph representation of each drug molecule, or only leverage the individual drug compound structures without using graph structure for the higher-level DDI graph. The key idea of our method is to fundamentally view the data as a bi-level graph, where the highest level graph represents the interaction between biological entities (interaction graph), and each biological entity itself is further expanded to its intrinsic graph representation (representation graphs), where the graph is either flat like a drug compound or hierarchical like a protein with amino acid level graph, secondary structure, tertiary structure, etc. Our model not only allows the usage of information from both the high-level interaction graph and the low-level representation graphs, but also offers a baseline for future research opportunities to address the bi-level nature of the data.
Side effects of prescribed medications are a common occurrence. Electronic healthcare databases present the opportunity to identify new side effects efficiently but currently the methods are limited due to confounding (i.e. when an association betwee
n two variables is identified due to them both being associated to a third variable). In this paper we propose a proof of concept method that learns common associations and uses this knowledge to automatically refine side effect signals (i.e. exposure-outcome associations) by removing instances of the exposure-outcome associations that are caused by confounding. This leaves the signal instances that are most likely to correspond to true side effect occurrences. We then calculate a novel measure termed the confounding-adjusted risk value, a more accurate absolute risk value of a patient experiencing the outcome within 60 days of the exposure. Tentative results suggest that the method works. For the four signals (i.e. exposure-outcome associations) investigated we are able to correctly filter the majority of exposure-outcome instances that were unlikely to correspond to true side effects. The method is likely to improve when tuning the association rule mining parameters for specific health outcomes. This paper shows that it may be possible to filter signals at a patient level based on association rules learned from considering patients medical histories. However, additional work is required to develop a way to automate the tuning of the methods parameters.
Modelling disease progression of iron deficiency anaemia (IDA) following oral iron supplement prescriptions is a prerequisite for evaluating the cost-effectiveness of oral iron supplements. Electronic health records (EHRs) from the Clinical Practice
Research Datalink (CPRD) provide rich longitudinal data on IDA disease progression in patients registered with 663 General Practitioner (GP) practices in the UK, but they also create challenges in statistical analyses. First, the CPRD data are clustered at multi-levels (i.e., GP practices and patients), but their large volume makes it computationally difficult to implement estimation of standard random effects models for multi-level data. Second, observation times in the CPRD data are irregular and could be informative about the disease progression. For example, shorter/longer gap times between GP visits could be associated with deteriorating/improving IDA. Existing methods to address informative observation times are mostly based on complex joint models, which adds more computational burden. To tackle these challenges, we develop a computationally efficient approach to modelling disease progression with EHRs data while accounting for variability at multi-level clusters and informative observation times. We apply the proposed method to the CPRD data to investigate IDA improvement and treatment intolerance following oral iron prescriptions in primary care of the UK.
الأسئلة المقترحة
سجل دخول لتتمكن من نشر تعليقات
التعليقات
جاري جلب التعليقات
سجل دخول لتتمكن من متابعة معايير البحث التي قمت باختيارها
